GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (CHIX:GXId) » Definitions » EPS (Diluted)

Gerresheimer AG (CHIX:GXID) EPS (Diluted) : €3.33 (TTM As of Aug. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Gerresheimer AG EPS (Diluted)?

Gerresheimer AG's Earnings per Share (Diluted) for the three months ended in Aug. 2024 was €0.79. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 was €3.33.

Gerresheimer AG's EPS (Basic) for the three months ended in Aug. 2024 was €0.79. Its EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2024 was €3.33.

Gerresheimer AG's EPS without NRI for the three months ended in Aug. 2024 was €0.79. Its EPS without NRI for the trailing twelve months (TTM) ended in Aug. 2024 was €3.33.

During the past 12 months, Gerresheimer AG's average EPS without NRIGrowth Rate was 1.20% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Gerresheimer AG's highest 3-Year average EPS without NRI Growth Rate was 116.80% per year. The lowest was -12.30% per year. And the median was 15.65% per year.


Gerresheimer AG EPS (Diluted) Historical Data

The historical data trend for Gerresheimer AG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG EPS (Diluted) Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.57 2.82 2.67 3.06 3.48

Gerresheimer AG Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 1.22 0.38 0.94 0.79

Competitive Comparison of Gerresheimer AG's EPS (Diluted)

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's PE Ratio falls into.



Gerresheimer AG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Gerresheimer AG's Diluted EPS for the fiscal year that ended in Nov. 2023 is calculated as

Diluted EPS (A: Nov. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(116.126-0)/33.336
=3.48

Gerresheimer AG's Diluted EPS for the quarter that ended in Aug. 2024 is calculated as

Diluted EPS (Q: Aug. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(27.209-0)/34.540
=0.79

EPS (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gerresheimer AG  (CHIX:GXId) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Gerresheimer AG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG Business Description

Traded in Other Exchanges
Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Gerresheimer AG Headlines

No Headlines